ERG and prostate cancer: For example, Tomlins and colleagues1 noticed that the ETV1 gene was overexpressed in 10%–20% of prostate cancer samples in multiple data sets and that the ERG gene was overexpressed in about 40% of prostate cancer samples in the same datasets.